CML Publications of the Month
As part of our monthly news service we would like to make you aware of important CML publications. From the many papers published in August, Professor Timothy Hughes has selected topical, interesting papers for your perusal. Papers with a clinical, scientific and low and middle income country focus are shared.
August 2026
Clinical CML papers
Health status impairments in tyrosine kinase inhibitor-treated chronic myeloid leukemia patients versus blood or bone marrow transplant survivors and non-cancer control
Bhatia S et al. Leukemia, August 2026
(epub ahead of print) – open access publication
Immunological mechanisms and therapeutic advances in chronic myeloid leukemia
Ybarra TK et al. Leukemia, August 2026
– open access publication
Dasatinib-induced pulmonary arterial hypertension
Musthafa Hafeesa N et al. JACC Case Rep, August 2026 (epub ahead of print) – open access publication
Nilotinib in chronic myeloid leukemia: Clinical value, real-world challenges, and the potential of nilotinib tablets to improve therapeutic outcomes
Sweet K et al. Expert Rev Hematol, August 2026 (epub ahead of print)
Postmarketing surveillance study of asciminib in patients with resistant/intolerant chronic myeloid leukemia in Japan
Yamaguchi K et al. Int J Hematol, August 2026 – open access publication
Renal dysfunction in patients with chronic myeloid leukemia on long-term first-line TKI therapy: a single-center analysis
Wang S et al. Oncologist, August 2026 – open access publication
From data to evidence: why administrative databases alone cannot measure real-world effectiveness in rare diseases – the case of chronic myeloid leukemia
Mucherino S et al. Leukemia, August 2026 – open access publication
Dual targeting of BCR::ABL1 and DNA methylation in advanced CML: A 3-year survival analysis of TKI-Azacitidine combination therapy
Yang Z et al. Ther Adv Hematol, August 2026 – open access publication
ELTS score and early “warning” define a two-stage risk framework for failure-free survival in chronic phase CML
Takagi F et al. Blood Adv, August 2026 (epub ahead of print) – open access publication
Further insights into the application of the TFR prognostic score (TPS) in CML patients attempting TFR
Claudiani S et al. Br J Haematol, August 2026
Scientific CML papers
Clonal and genomic determinants of e1a2 BCR::ABL1 chronic myeloid leukemia: A Fi-LMC study
Podvin B et al. Hemasphere, August 2026 – open access publication
Peripheral blood profiles reflecting progenitor lineage balance are associated with molecular response in chronic myeloid leukemia
Suzuki K et al. Exp Hematol, August 2026 (epub ahead of print)
LMIC CML papers
Blurring the lines: NPM1 mutation in blast phase CML challenges traditional paradigms
Gajendra S et al. Indian J Hematol Blood Transfus, July 2026